Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Others

Fractyl Health (GUTS) Other financing activities (2023 - 2024)

Fractyl Health's Other financing activities history spans 2 years, with the latest figure at $2.9 million for Q1 2024.

For the quarter ending Q1 2024, Other financing activities changed N/A year-over-year to $2.9 million, compared with a TTM value of $2.9 million through Dec 2024, changed N/A, and an annual FY2024 reading of $2.9 million, up 613.5% over the prior year.
Other financing activities for Q1 2024 was $2.9 million at Fractyl Health, up from $73000.0 in the prior quarter.
The five-year high for Other financing activities was $2.9 million in Q1 2024, with the low at $73000.0 in Q4 2023.